Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Prothena Corporation Plc - news published 295 - readings 7.019

BACK

Prothena Corporation plc

Additional Proxy Soliciting Materials (Form DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) ...

28.03.2025

Prothena Corporation plc

Proxy Statement (Form DEF 14A)

TAB LE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ____________________ Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, ...

28.03.2025

Prothena Corporation plc

Director's Report and Financial Statements for Fiscal Year 2024

Prothena Corporation plc Directors' Report and Consolidated Financial Statements For the Year Ended 31 December 2024 Registered number: 518146 Prothena Corporation plc Directors' Report and Financial Statements Page Directors' Report ................................................................................................................................................. ...

28.03.2025

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSIO ...

07.03.2025

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

07.03.2025

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

07.03.2025

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

07.03.2025

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

07.03.2025

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

07.03.2025

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

07.03.2025

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

07.03.2025

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

07.03.2025

Prothena Corporation plc

Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS In addition to historical information, this Form 10-K contains forward-looking statements which may cause our actual results to differ materially from expectations, plans and anticipated results discussed in forward-looking statements. Factors that could cause our actual results to differ mat ...

27.02.2025

Prothena Corporation plc

Prothena Reports Fourth Quarter 2024 Financial Results and Business Highlights

Prothena Fourth Quarter and Year-End 2024 Financial Results February 20, 2025 4Q and FY24 Earnings Call Agenda Welcome Mark Johnson | Vice President of Investor Relations Opening Remarks Gene Kinney, Ph.D. | President and CEO R&D Update Chad Swanson, Ph.D. | Chief Development Officer Commercial Update Brandon Smith | Chief Operating Officer Financial Results Tran Nguyen | ...

20.02.2025

Prothena Corporation plc

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights (Form 8-K)

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights •Net cash used in operating and investing activities was $47.8 million in the fourth quarter and $150.3 million for the full year of 2024; quarter-end cash and restricted cash position was $472.2 million •The company expects cash guidance for the fu ...

20.02.2025

Prothena Corporation Plc - news published 295 - readings 7.019

Prothena Corporation plc

Additional Proxy Soliciting Materials (Form DEFA14A)

Prothena Corporation plc

Proxy Statement (Form DEF 14A)

Prothena Corporation plc

Director's Report and Financial Statements for Fiscal Year 2024

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

Prothena Corporation plc

Statement of Changes in Beneficial Ownership (Form 4)

Prothena Corporation plc

Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)

Prothena Corporation plc

Prothena Reports Fourth Quarter 2024 Financial Results and Business Highlights

Prothena Corporation plc

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights (Form 8-K)

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member